The objective of this study was to assess striatal dopamine transporter availability in patients with advanced Parkinson's disease (PD) before and after 13 months of unilateral extradural motor cortex stimulation (EMCS) with [I]N-ω-fluoropropyl-2-β-carbo-methoxy-3-β-(4-iodophenyl)nortropane single photon emission computed tomography (I-FP-CIT SPECT).
Di Giuda, D., Calcagni, M. L., Totaro, M., Cocciolillo, F., Piano, C., Soleti, F., Fasano, A., Cioni, B., Bentivoglio, A. R., Giordano, A., Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report, <<NUCLEAR MEDICINE COMMUNICATIONS>>, N/A; 33 (9): 933-940. [doi:10.1097/MNM.0b013e3283561810] [http://hdl.handle.net/10807/27722]
Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report
Di Giuda, Daniela;Calcagni, Maria Lucia;Piano, Carla;Soleti, Francesco;Fasano, Alfonso;Cioni, Beatrice;Bentivoglio, Anna Rita;Giordano, Alessandro
2012
Abstract
The objective of this study was to assess striatal dopamine transporter availability in patients with advanced Parkinson's disease (PD) before and after 13 months of unilateral extradural motor cortex stimulation (EMCS) with [I]N-ω-fluoropropyl-2-β-carbo-methoxy-3-β-(4-iodophenyl)nortropane single photon emission computed tomography (I-FP-CIT SPECT).
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
